Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10244)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 26, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Houshmand M, Blanco TM, Circosta P, Yazdi N, Kazemi A, Saglio G, Zarif MN. Bone marrow microenvironment: The guardian of leukemia stem cells. World J Stem Cells 2019; 11(8): 476-490 [PMID: 31523368 DOI: 10.4252/wjsc.v11.i8.476] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v11/i8/476.htm |
| Number | Citing Articles |
| 1 |
Mahdi Pakjoo, Seyed Esmaeil Ahmadi, Mohammad Zahedi, Niloofar Jaafari, Reyhane Khademi, Ali Amini, Majid Safa. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01433-5
|
| 2 |
Mohammad Houshmand, Alireza Kazemi, Ali Anjam Najmedini, Muhammad Shahzad Ali, Valentina Gaidano, Alessandro Cignetti, Carmen Fava, Daniela Cilloni, Giuseppe Saglio, Paola Circosta. Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells. Journal of Clinical Medicine 2021; 10(24): 5805 doi: 10.3390/jcm10245805
|
| 3 |
Yongsheng Ruan, Hye Na Kim, Heather Ogana, Yong-Mi Kim. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment. International Journal of Molecular Sciences 2020; 21(17): 6247 doi: 10.3390/ijms21176247
|
| 4 |
Hend E. El-Shaqanqery, Rania Hassan Mohamed, Ahmed A. Sayed. Mitochondrial Effects on Seeds of Cancer Survival in Leukemia. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.745924
|
| 5 |
Alessia Oppezzo, Lovely Monney, Henri Kilian, Lofti Slimani, Frédérique Maczkowiak-Chartois, Filippo Rosselli. Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFα. Cell & Bioscience 2023; 13(1) doi: 10.1186/s13578-023-01067-7
|
| 6 |
Hye Na Kim, Yongsheng Ruan, Heather Ogana, Yong-Mi Kim. Cadherins, Selectins, and Integrins in CAM-DR in Leukemia. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.592733
|
| 7 |
Mohammad Houshmand, Francesca Garello, Rachele Stefania, Valentina Gaidano, Alessandro Cignetti, Michela Spinelli, Carmen Fava, Mahin Nikougoftar Zarif, Sara Galimberti, Ester Pungolino, Mario Annunziata, Luigia Luciano, Giorgina Specchia, Monica Bocchia, Gianni Binotto, Massimiliano Bonifacio, Bruno Martino, Patrizia Pregno, Fabio Stagno, Alessandra Iurlo, Sabina Russo, Silvio Aime, Paola Circosta, Giuseppe Saglio. Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome. Cancers 2021; 13(6): 1311 doi: 10.3390/cancers13061311
|
| 8 |
Lihui Lin, Yin Tong, Jasmin Straube, Jinyan Zhao, Yanting Gao, Ping Bai, Jia Li, Juan Wang, Hongling Wang, Xiaorui Wang, Sheng Huang, Wen Xu, Xianmin Song, Li Li.
Ex-vivo drug testing predicts chemosensitivity in acute myeloid leukemia. Journal of Leukocyte Biology 2020; 107(5): 859 doi: 10.1002/JLB.5A0220-676RR
|
| 9 |
Michael Chamo, Omri Koren, Oron Goldstein, Nir Bujanover, Nurit Keinan, Ye’ela Scharff, Roi Gazit. Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells. Cancers 2023; 15(3): 720 doi: 10.3390/cancers15030720
|
| 10 |
Deepshi Thakral, Ritu Gupta, Aafreen Khan. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches. Stem Cell Reviews and Reports 2022; 18(5): 1756 doi: 10.1007/s12015-022-10349-5
|
| 11 |
Zhenlong Li, Rui Ma, Shoubao Ma, Lei Tian, Ting Lu, Jianying Zhang, Bethany L. Mundy-Bosse, Bin Zhang, Guido Marcucci, Michael A. Caligiuri, Jianhua Yu. ILC1s control leukemia stem cell fate and limit development of AML. Nature Immunology 2022; 23(5): 718 doi: 10.1038/s41590-022-01198-y
|
| 12 |
Mohammad Houshmand, Francesca Garello, Paola Circosta, Rachele Stefania, Silvio Aime, Giuseppe Saglio, Claudia Giachino. Nanocarriers as Magic Bullets in the Treatment of Leukemia. Nanomaterials 2020; 10(2): 276 doi: 10.3390/nano10020276
|
| 13 |
Golnaz Ensieh Kazemi-Sefat, Mohammad Keramatipour, Mohammad Vaezi, Seyed Mohsen Razavi, Kaveh Kavousi, Amin Talebi, Shahrbano Rostami, Marjan Yaghmaie, Bahram Chahardouli, Saeed Talebi, Kazem Mousavizadeh. Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17232-w
|
| 14 |
Jie Shen, Zhiguo Lu, Jianze Wang, Tianlu Zhang, Jun Yang, Yan Li, Guiying Liu, Xin Zhang. Advances of Nanoparticles for Leukemia Treatment. ACS Biomaterials Science & Engineering 2020; 6(12): 6478 doi: 10.1021/acsbiomaterials.0c01040
|
| 15 |
Fausto Castagnetti, Gianni Binotto, Isabella Capodanno, Atto Billio, Elisabetta Calistri, Francesco Cavazzini, Monica Crugnola, Antonella Gozzini, Gabriele Gugliotta, Mauro Krampera, Alessandro Lucchesi, Anna Merli, Maria Cristina Miggiano, Claudia Minotto, Monica Poggiaspalla, Marzia Salvucci, Barbara Scappini, Mario Tiribelli, Elena Trabacchi, Gianantonio Rosti, Sara Galimberti, Massimiliano Bonifacio. Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools. Targeted Oncology 2021; 16(6): 823 doi: 10.1007/s11523-021-00831-4
|
| 16 |
Dorian Forte, Martina Barone, Francesca Palandri, Lucia Catani. The “Vesicular Intelligence” Strategy of Blood Cancers. Genes 2021; 12(3): 416 doi: 10.3390/genes12030416
|
| 17 |
Harinder Gill, Emily Lee, Pinky Mo. Pathogenesis and Treatment of Leukemia. 2023; : 663 doi: 10.1007/978-981-99-3810-0_52
|
| 18 |
Domenico Russo, José Valentín Garcia-Gutierrez, Simona Soverini, Michele Baccarani. Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives. Journal of Clinical Medicine 2020; 9(6): 1709 doi: 10.3390/jcm9061709
|
| 19 |
Natalia-Del Pilar Vanegas, Paola Fernanda Ruiz-Aparicio, Gloria Inés Uribe, Adriana Linares-Ballesteros, Jean-Paul Vernot. Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells. International Journal of Molecular Sciences 2021; 22(15): 8166 doi: 10.3390/ijms22158166
|
| 20 |
Eunjung Kim, Eo-Jin Hwang, Junghye Lee, Dae-Young Kim, Jae-Young Kim, Dong-Wook Kim. Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia. Neoplasia 2022; 32: 100817 doi: 10.1016/j.neo.2022.100817
|
| 21 |
Iga Stukan, Marek Gryzik, Grażyna Hoser, Andrew Want, Wioleta Grabowska-Pyrzewicz, Mikolaj Zdioruk, Mariola Napiórkowska, Marcin Cieślak, Karolina Królewska-Golińska, Barbara Nawrot, Grzegorz Basak, Urszula Wojda. Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients’ CD34+/CD38− Leukemia Stem Cells. Cancers 2022; 14(15): 3641 doi: 10.3390/cancers14153641
|
| 22 |
Xingjian Zhai, Xiaoyan Jiang. Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias. Biomedicines 2022; 10(8): 1841 doi: 10.3390/biomedicines10081841
|
| 23 |
Yammy Yung, Emily Lee, Hiu-Tung Chu, Pui-Kwan Yip, Harinder Gill. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms. International Journal of Molecular Sciences 2021; 22(2): 659 doi: 10.3390/ijms22020659
|
| 24 |
Treatment of Acute Myeloid Leukemia: A Concise Overview. Abasyn Journal Life Sciences 2020; : 111 doi: 10.34091/AJLS.3.2.11
|
| 25 |
Mahmoud Alhosin, Syed Shoeb I. Razvi, Ryan A. Sheikh, Jalaluddin A. Khan, Mazin A. Zamzami, Hani Choudhry. Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways. Technology in Cancer Research & Treatment 2020; 19: 153303382094748 doi: 10.1177/1533033820947489
|
| 26 |
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, Masoud Salavati-Niasari, Mahnaz Amiri. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01822-7
|
| 27 |
Laura Damele, Selene Ottonello, Maria Cristina Mingari, Gabriella Pietra, Chiara Vitale. Targeted Therapies: Friends or Foes for Patient’s NK Cell-Mediated Tumor Immune-Surveillance?. Cancers 2020; 12(4): 774 doi: 10.3390/cancers12040774
|
| 28 |
Harinad Maganti, Alissa Visram, Risa Shorr, Jill Fulcher, Mitchell Sabloff, David S. Allan. Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies. Leukemia Research 2020; 97: 106442 doi: 10.1016/j.leukres.2020.106442
|